vs
Side-by-side financial comparison of Hims & Hers Health, Inc. (HIMS) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Hims & Hers Health, Inc. is the larger business by last-quarter revenue ($617.8M vs $39.6M, roughly 15.6× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 3.3%, a 32.6% gap on every dollar of revenue. On growth, Hims & Hers Health, Inc. posted the faster year-over-year revenue change (28.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-2.5M). Over the past eight quarters, Hims & Hers Health, Inc.'s revenue compounded faster (49.0% CAGR vs -15.0%).
Hims & Hers Health, Inc. is an American telehealth company established in 2017. The company provides prescription medications, over-the-counter medications, and personal care products.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
HIMS vs SBC — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $617.8M | $39.6M |
| Net Profit | $20.6M | $14.2M |
| Gross Margin | 71.9% | 73.1% |
| Operating Margin | 1.5% | 32.5% |
| Net Margin | 3.3% | 35.9% |
| Revenue YoY | 28.4% | -10.9% |
| Net Profit YoY | -20.8% | 117.2% |
| EPS (diluted) | $0.08 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $617.8M | $39.6M | ||
| Q3 25 | $599.0M | $43.4M | ||
| Q2 25 | $544.8M | $43.4M | ||
| Q1 25 | $586.0M | $47.3M | ||
| Q4 24 | $481.1M | $44.4M | ||
| Q3 24 | $401.6M | $53.1M | ||
| Q2 24 | $315.6M | $53.1M | ||
| Q1 24 | $278.2M | $54.8M |
| Q4 25 | $20.6M | $14.2M | ||
| Q3 25 | $15.8M | $12.8M | ||
| Q2 25 | $42.5M | $2.5M | ||
| Q1 25 | $49.5M | $21.5M | ||
| Q4 24 | $26.0M | $6.5M | ||
| Q3 24 | $75.6M | $2.8M | ||
| Q2 24 | $13.3M | $18.5M | ||
| Q1 24 | $11.1M | $18.8M |
| Q4 25 | 71.9% | 73.1% | ||
| Q3 25 | 73.8% | 70.6% | ||
| Q2 25 | 76.4% | 69.2% | ||
| Q1 25 | 73.5% | 79.7% | ||
| Q4 24 | 76.8% | 76.3% | ||
| Q3 24 | 79.2% | 81.5% | ||
| Q2 24 | 81.3% | 74.2% | ||
| Q1 24 | 82.4% | 72.1% |
| Q4 25 | 1.5% | 32.5% | ||
| Q3 25 | 2.0% | 36.6% | ||
| Q2 25 | 4.9% | 33.6% | ||
| Q1 25 | 9.9% | 51.1% | ||
| Q4 24 | 3.9% | 10.6% | ||
| Q3 24 | 5.6% | 26.1% | ||
| Q2 24 | 3.5% | 51.4% | ||
| Q1 24 | 3.6% | 44.6% |
| Q4 25 | 3.3% | 35.9% | ||
| Q3 25 | 2.6% | 29.6% | ||
| Q2 25 | 7.8% | 5.7% | ||
| Q1 25 | 8.4% | 45.4% | ||
| Q4 24 | 5.4% | 14.7% | ||
| Q3 24 | 18.8% | 5.3% | ||
| Q2 24 | 4.2% | 34.8% | ||
| Q1 24 | 4.0% | 34.2% |
| Q4 25 | $0.08 | $0.15 | ||
| Q3 25 | $0.06 | $0.12 | ||
| Q2 25 | $0.17 | $0.02 | ||
| Q1 25 | $0.20 | $0.21 | ||
| Q4 24 | $0.10 | $0.05 | ||
| Q3 24 | $0.32 | $0.03 | ||
| Q2 24 | $0.06 | $0.20 | ||
| Q1 24 | $0.05 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $228.6M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $540.9M | $248.3M |
| Total Assets | $2.2B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $228.6M | $164.1M | ||
| Q3 25 | $345.8M | $127.4M | ||
| Q2 25 | $1.1B | $152.7M | ||
| Q1 25 | $273.7M | $132.1M | ||
| Q4 24 | $220.6M | $125.0M | ||
| Q3 24 | $165.5M | $137.4M | ||
| Q2 24 | $129.3M | — | ||
| Q1 24 | $105.2M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $540.9M | $248.3M | ||
| Q3 25 | $581.0M | $248.0M | ||
| Q2 25 | $562.7M | $244.6M | ||
| Q1 25 | $549.3M | $226.4M | ||
| Q4 24 | $476.7M | $195.1M | ||
| Q3 24 | $440.1M | $205.0M | ||
| Q2 24 | $362.0M | $8.8M | ||
| Q1 24 | $344.5M | $9.0M |
| Q4 25 | $2.2B | $380.4M | ||
| Q3 25 | $2.2B | $321.4M | ||
| Q2 25 | $1.9B | $315.3M | ||
| Q1 25 | $891.7M | $284.6M | ||
| Q4 24 | $707.5M | $266.1M | ||
| Q3 24 | $602.3M | $296.5M | ||
| Q2 24 | $480.5M | $19.5M | ||
| Q1 24 | $448.1M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.3M | $52.0M |
| Free Cash FlowOCF − Capex | $-2.5M | $51.2M |
| FCF MarginFCF / Revenue | -0.4% | 129.3% |
| Capex IntensityCapex / Revenue | 10.3% | 2.0% |
| Cash ConversionOCF / Net Profit | 2.98× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $57.4M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $61.3M | $52.0M | ||
| Q3 25 | $148.7M | $-20.9M | ||
| Q2 25 | $-19.1M | $-8.3M | ||
| Q1 25 | $109.1M | $1.9M | ||
| Q4 24 | $86.4M | $-7.3M | ||
| Q3 24 | $85.3M | $5.0M | ||
| Q2 24 | $53.6M | $19.2M | ||
| Q1 24 | $25.8M | $3.7M |
| Q4 25 | $-2.5M | $51.2M | ||
| Q3 25 | $79.3M | $-20.9M | ||
| Q2 25 | $-69.5M | $-8.6M | ||
| Q1 25 | $50.1M | $1.7M | ||
| Q4 24 | $59.5M | $-7.9M | ||
| Q3 24 | $79.4M | $4.6M | ||
| Q2 24 | $47.6M | $18.3M | ||
| Q1 24 | $11.8M | $3.0M |
| Q4 25 | -0.4% | 129.3% | ||
| Q3 25 | 13.2% | -48.3% | ||
| Q2 25 | -12.8% | -19.9% | ||
| Q1 25 | 8.5% | 3.5% | ||
| Q4 24 | 12.4% | -17.8% | ||
| Q3 24 | 19.8% | 8.7% | ||
| Q2 24 | 15.1% | 34.5% | ||
| Q1 24 | 4.3% | 5.4% |
| Q4 25 | 10.3% | 2.0% | ||
| Q3 25 | 11.6% | 0.1% | ||
| Q2 25 | 9.3% | 0.7% | ||
| Q1 25 | 10.1% | 0.5% | ||
| Q4 24 | 5.6% | 1.3% | ||
| Q3 24 | 1.5% | 0.8% | ||
| Q2 24 | 1.9% | 1.6% | ||
| Q1 24 | 5.0% | 1.3% |
| Q4 25 | 2.98× | 3.66× | ||
| Q3 25 | 9.43× | -1.63× | ||
| Q2 25 | -0.45× | -3.39× | ||
| Q1 25 | 2.20× | 0.09× | ||
| Q4 24 | 3.32× | -1.12× | ||
| Q3 24 | 1.13× | 1.77× | ||
| Q2 24 | 4.03× | 1.04× | ||
| Q1 24 | 2.32× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIMS
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
